Filing Details
- Accession Number:
- 0001209191-11-037276
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-01 16:59:12
- Reporting Period:
- 2011-06-29
- Filing Date:
- 2011-07-01
- Accepted Time:
- 2011-07-01 16:59:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341407 | S David Utterberg | C/O Nxstage Medical, Inc. 439 South Union Street, 5Th Floor Lawrence MA 01843 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-06-29 | 50,000 | $20.38 | 4,960,538 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-06-30 | 48,546 | $20.54 | 4,911,992 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-06-30 | 156 | $0.00 | 4,912,148 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2010, and amended on March 11, 2011.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.26 to $20.49. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.34 to $20.87. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above
- Pursuant to the issuer's director compensation policy, non-employee directors may elect to receive shares of the issuer's common stock in lieu of cash compensation payable pursuant to such policy. Payments of common stock in lieu of cash compensation are made quarterly in the amount of the total cash compensation earned by a non-employee director during such quarter divided by the closing price of the issuer's common stock on the last day of the quarter. The closing price of the issuer's common stock on June 30, 2011, the last trading day of the quarter, was $20.82.
Billionaire Hedge Funds
